These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 27561828)
1. Knockdown of Myosin 6 inhibits proliferation of oral squamous cell carcinoma cells. Zhang X; Huang Z; Hu Y; Liu L J Oral Pathol Med; 2016 Nov; 45(10):740-745. PubMed ID: 27561828 [TBL] [Abstract][Full Text] [Related]
2. MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40. Wang D; Zhu L; Liao M; Zeng T; Zhuo W; Yang S; Wu W Oncol Rep; 2016 Sep; 36(3):1285-92. PubMed ID: 27431378 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of myosin VI reduced cell growth and increased apoptosis in human colorectal cancer. You W; Tan G; Sheng N; Gong J; Yan J; Chen D; Zhang H; Wang Z Acta Biochim Biophys Sin (Shanghai); 2016 May; 48(5):430-6. PubMed ID: 27044563 [TBL] [Abstract][Full Text] [Related]
4. Lentivirus-Mediated Silencing of Myosin VI Inhibits Proliferation and Cell Cycle Progression in Human Lung Cancer Cells. Yu H; Zhu Z; Chang J; Wang J; Shen X Chem Biol Drug Des; 2015 Oct; 86(4):606-13. PubMed ID: 25643992 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of myosin VI regulates gastric cancer cell progression. Wang Z; Ying M; Wu Q; Wang R; Li Y Gene; 2016 Nov; 593(1):100-109. PubMed ID: 27515005 [TBL] [Abstract][Full Text] [Related]
6. Circular RNA_0076977 contributes to oral squamous cell carcinoma progression through mediating microRNA-802 axis. Hei N; Chen Y; Peng S; Bao Y; Jin L Arch Oral Biol; 2022 Dec; 144():105567. PubMed ID: 36265392 [TBL] [Abstract][Full Text] [Related]
7. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma. Qiu K; Huang Z; Huang Z; He Z; You S Arch Oral Biol; 2016 Jun; 66():92-7. PubMed ID: 26943814 [TBL] [Abstract][Full Text] [Related]
8. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway. Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of USP39 by lentivirus-mediated RNA interference suppresses the growth of oral squamous cell carcinoma. Li KY; Zhang J; Jiang LC; Zhang B; Xia CP; Xu K; Chen HY; Yang QZ; Liu SW; Zhu H Cancer Biomark; 2016; 16(1):137-144. PubMed ID: 26835714 [TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma. Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663 [TBL] [Abstract][Full Text] [Related]
11. CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma. Zhuang XM; Zhou B J Oral Pathol Med; 2019 Feb; 48(2):122-128. PubMed ID: 30554431 [TBL] [Abstract][Full Text] [Related]
12. [Effect of human trophoblast cell-surface antigen 2 gene expression by RNA interference on proliferation and apoptosis of tongue squamous cell carcinoma and its mechanism]. Fang Z; Chen S; Zhao JF; Sun Q; Qiu F; Li XM Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Sep; 53(9):640-644. PubMed ID: 30196628 [No Abstract] [Full Text] [Related]
13. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation. Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957 [TBL] [Abstract][Full Text] [Related]
14. The role of miR-21 in proliferation and invasion capacity of human tongue squamous cell carcinoma in vitro. Wang Y; Zhu Y; Lv P; Li L Int J Clin Exp Pathol; 2015; 8(5):4555-63. PubMed ID: 26191145 [TBL] [Abstract][Full Text] [Related]
15. FRMD4A: A potential therapeutic target for the treatment of tongue squamous cell carcinoma. Zheng X; Jia B; Lin X; Han J; Qiu X; Chu H; Sun X; Hu W; Pan J; Chen J; Zhao J Int J Mol Med; 2016 Nov; 38(5):1443-1449. PubMed ID: 27666346 [TBL] [Abstract][Full Text] [Related]
16. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma. Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of tumor protein D52-like 2 induces cell growth inhibition and apoptosis in oral squamous cell carcinoma. He Y; Chen F; Cai Y; Chen S Cell Biol Int; 2015 Mar; 39(3):264-71. PubMed ID: 25262828 [TBL] [Abstract][Full Text] [Related]
18. HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma. Zhang H; Tang Z; Deng C; He Y; Wu F; Liu O; Hu C Oral Dis; 2017 Mar; 23(2):255-264. PubMed ID: 27809392 [TBL] [Abstract][Full Text] [Related]
19. Integrin α7 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma. Lv Z; Yang Y; Yang C Int J Oncol; 2020 Jan; 56(1):69-84. PubMed ID: 31789398 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells. Li B; Li YM; He WT; Chen H; Zhu HW; Liu T; Zhang JH; Song TN; Zhou YL Oncol Rep; 2016 Jul; 36(1):223-30. PubMed ID: 27176873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]